9-135714596-G-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_020822.3(KCNT1):c.130G>T(p.Gly44Cys) variant causes a missense change. The variant allele was found at a frequency of 0.0000967 in 1,395,890 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.000053 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00010 ( 0 hom. )
Consequence
KCNT1
NM_020822.3 missense
NM_020822.3 missense
Scores
4
12
Clinical Significance
Conservation
PhyloP100: 4.76
Publications
2 publications found
Genes affected
KCNT1 (HGNC:18865): (potassium sodium-activated channel subfamily T member 1) Potassium channels represent the most complex class of voltage-gated ion channels from both functional and structural standpoints. Their diverse functions include regulating neurotransmitter release, heart rate, insulin secretion, neuronal excitability, epithelial electrolyte transport, smooth muscle contraction, and cell volume. This gene encodes a sodium-activated potassium channel subunit which is thought to function in ion conductance and developmental signaling pathways. Mutations in this gene cause the early-onset epileptic disorders, malignant migrating partial seizures of infancy and autosomal dominant nocturnal frontal lobe epilepsy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2012]
KCNT1 Gene-Disease associations (from GenCC):
- childhood-onset epilepsy syndromeInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- developmental and epileptic encephalopathy, 14Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
- malignant migrating partial seizures of infancyInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
- autosomal dominant nocturnal frontal lobe epilepsy 5Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- autosomal dominant nocturnal frontal lobe epilepsyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.03228596).
BP6
Variant 9-135714596-G-T is Benign according to our data. Variant chr9-135714596-G-T is described in ClinVar as [Likely_benign]. Clinvar id is 473358.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population mid. GnomAdExome4 allele frequency = 0.000102 (127/1246268) while in subpopulation MID AF = 0.00108 (4/3696). AF 95% confidence interval is 0.000808. There are 0 homozygotes in GnomAdExome4. There are 82 alleles in the male GnomAdExome4 subpopulation. Median coverage is 30. This position passed quality control check.
BS2
High AC in GnomAd4 at 8 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCNT1 | NM_020822.3 | c.130G>T | p.Gly44Cys | missense_variant | Exon 2 of 31 | ENST00000371757.7 | NP_065873.2 | |
KCNT1 | XM_011518878.4 | c.265G>T | p.Gly89Cys | missense_variant | Exon 2 of 31 | XP_011517180.1 | ||
KCNT1 | XM_011518879.4 | c.265G>T | p.Gly89Cys | missense_variant | Exon 2 of 31 | XP_011517181.1 | ||
KCNT1 | NM_001272003.2 | c.110+12228G>T | intron_variant | Intron 1 of 30 | NP_001258932.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000535 AC: 8AN: 149518Hom.: 0 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
8
AN:
149518
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000212 AC: 34AN: 160066 AF XY: 0.000295 show subpopulations
GnomAD2 exomes
AF:
AC:
34
AN:
160066
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000102 AC: 127AN: 1246268Hom.: 0 Cov.: 30 AF XY: 0.000132 AC XY: 82AN XY: 618908 show subpopulations
GnomAD4 exome
AF:
AC:
127
AN:
1246268
Hom.:
Cov.:
30
AF XY:
AC XY:
82
AN XY:
618908
show subpopulations
African (AFR)
AF:
AC:
0
AN:
25008
American (AMR)
AF:
AC:
0
AN:
30398
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
19126
East Asian (EAS)
AF:
AC:
1
AN:
24328
South Asian (SAS)
AF:
AC:
68
AN:
68048
European-Finnish (FIN)
AF:
AC:
0
AN:
36784
Middle Eastern (MID)
AF:
AC:
4
AN:
3696
European-Non Finnish (NFE)
AF:
AC:
45
AN:
991700
Other (OTH)
AF:
AC:
9
AN:
47180
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.510
Heterozygous variant carriers
0
6
12
18
24
30
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.0000535 AC: 8AN: 149622Hom.: 0 Cov.: 32 AF XY: 0.0000548 AC XY: 4AN XY: 73016 show subpopulations
GnomAD4 genome
AF:
AC:
8
AN:
149622
Hom.:
Cov.:
32
AF XY:
AC XY:
4
AN XY:
73016
show subpopulations
African (AFR)
AF:
AC:
0
AN:
41248
American (AMR)
AF:
AC:
0
AN:
15060
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3432
East Asian (EAS)
AF:
AC:
0
AN:
5136
South Asian (SAS)
AF:
AC:
2
AN:
4824
European-Finnish (FIN)
AF:
AC:
0
AN:
9554
Middle Eastern (MID)
AF:
AC:
1
AN:
290
European-Non Finnish (NFE)
AF:
AC:
5
AN:
67094
Other (OTH)
AF:
AC:
0
AN:
2072
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.544
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
25
ClinVar
Significance: Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:4
Jan 29, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Aug 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
KCNT1: BS2 -
Developmental and epileptic encephalopathy, 14;C3554306:Autosomal dominant nocturnal frontal lobe epilepsy 5 Benign:1
Oct 21, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Developmental and epileptic encephalopathy, 14 Benign:1
Mar 15, 2022
Genome-Nilou Lab
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Autosomal dominant nocturnal frontal lobe epilepsy 5 Benign:1
Mar 15, 2022
Genome-Nilou Lab
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
DANN
Uncertain
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T;T
M_CAP
Uncertain
D
MetaRNN
Benign
T;T
MetaSVM
Benign
T
PhyloP100
PrimateAI
Uncertain
T
PROVEAN
Benign
.;N
REVEL
Benign
Sift
Benign
.;D
Sift4G
Uncertain
D;D
Vest4
MutPred
Loss of disorder (P = 0.0746);Loss of disorder (P = 0.0746);
MVP
MPC
0.85
ClinPred
T
GERP RS
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.